[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editor's Correspondence
May 22, 2000

Overestimation of the Number of Individuals With Hypertension Who Are Eligible for Treatment According to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Arch Intern Med. 2000;160(10):1537-1538. doi:

In a study by Lloyd-Jones et al,1 the impact of the recently published Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI) on the number of subjects with hypertension who are eligible for treatment was estimated. Using data from the Framingham Heart Study, Lloyd-Jones et al estimated that according to the JNC-VI guidelines, 60.6% of the subjects in the high-normal or hypertensive group were eligible for initial drug therapy or were already receiving drug therapy. From the data that were presented in this study, it can be derived that 13.5% of the subjects in the high-normal or hypertensive group were eligible for initial pharmacological treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×